KOR  ENG
  • IR

  • AbClon’s strong foundations and innovative platforms will help drive the future of
    personalized medicine and safeguard the health and hopes of families.

IR자료

제목 [한양증권] 차별화된 항체신약 플랫폼 보유
첨부파일 한양증권_임동락_앱클론.pdf (1.1M) 날짜 2018-12-17 조회 309

1. 제목 : 차별화된 항체신약 플랫폼 보유

 

2. 기관명 : 한양증권

 

3. 작성자 : 임동락 연구원

 

4. 분량 : 3page

 

5. 발간일 : 2018.12.17

Designed by CHAIRONE
© AbClon. All rights reserved.